These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23232186)

  • 1. Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions.
    Yu L; Wang L; Chen S
    Biochim Biophys Acta; 2013 Apr; 1835(2):144-54. PubMed ID: 23232186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR signaling by tumor and immune cells: a double-edged sword.
    Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
    Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
    Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
    Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?
    Yu L; Wang L; Chen S
    Cell Mol Life Sci; 2012 Mar; 69(6):935-49. PubMed ID: 22048194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.
    Dajon M; Iribarren K; Cremer I
    Immunobiology; 2017 Jan; 222(1):89-100. PubMed ID: 27349597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis.
    McGettrick AF; O'Neill LA
    Br J Haematol; 2007 Oct; 139(2):185-93. PubMed ID: 17897294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toll-like receptors in development and function of the hematopoietic system].
    Vadillo E; Pelayo R
    Rev Invest Clin; 2012; 64(5):461-76. PubMed ID: 23544309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor signaling in parasitic infections.
    Ashour DS
    Expert Rev Clin Immunol; 2015 Jun; 11(6):771-80. PubMed ID: 25896399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Toll-Like Receptors for Cancer Therapy.
    Braunstein MJ; Kucharczyk J; Adams S
    Target Oncol; 2018 Oct; 13(5):583-598. PubMed ID: 30229471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention.
    Zou H; Wang WK; Liu YL; Braddock M; Zheng MH; Huang DS
    Expert Opin Ther Targets; 2016 Sep; 20(9):1127-35. PubMed ID: 26998881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis.
    Sabroe I; Dower SK; Whyte MK
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S421-6. PubMed ID: 16237641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Toll-like receptor signaling pathways in innate immune responses.
    Qian C; Cao X
    Ann N Y Acad Sci; 2013 Apr; 1283():67-74. PubMed ID: 23163321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors: cost or benefit for cancer?
    Matijevic T; Pavelic J
    Curr Pharm Des; 2010; 16(9):1081-90. PubMed ID: 20030618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors, inflammation and cancer.
    Tsan MF
    Semin Cancer Biol; 2006 Feb; 16(1):32-7. PubMed ID: 16153858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.
    Broering R; Montag M; Jiang M; Lu M; Sowa JP; Kleinehr K; Gerken G; Schlaak JF
    Int Immunol; 2011 Sep; 23(9):537-44. PubMed ID: 21750146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To con protection: TIR-domain containing proteins (Tcp) and innate immune evasion.
    Patterson NJ; Werling D
    Vet Immunol Immunopathol; 2013 Sep; 155(3):147-54. PubMed ID: 23871438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor agonists: a patent review (2011 - 2013).
    Hussein WM; Liu TY; Skwarczynski M; Toth I
    Expert Opin Ther Pat; 2014 Apr; 24(4):453-70. PubMed ID: 24456079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.